No Data
No Data
Cathay Biotech Inc. (688065.SH): accumulated buyback of 0.1629% of shares.
Cathay Biotech Inc. (688065.SH) announced on July 1st that as of June 30th, 2024, the company repurchased 950,464 shares of the company's stock through the Shanghai Stock Exchange trading system with a centralized bidding trading method, accounting for 0.1629% of the company's total share capital of 583,378,039 shares. The highest price for repurchase was 57.37 yuan/share and the lowest was 38.98 yuan/share, with a total amount of CNY 49,415,764.27 (excluding stamp duty, transaction commissions and other transaction costs).
Some Investors May Be Worried About Cathay Biotech's (SHSE:688065) Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Typically, we'll want to notice a trend of growing return on capital employed (RO
Tianjin Sitong, the shareholder of Kaisai Biotech (688065.SH), and its co-actors reduced their holdings by 4.921,000 shares
Zhitong Finance App News, Kaisai Biotech (688065.SH) issued an announcement. On May 24, 2024, the company received the “Notice Letter on the Halfway Reduction of Shares and the Progress of Shareholding Reduction” from the shareholder Tianjin Sitong Longtongyuan Enterprise Management Partnership (“Tianjin Sitong”) and its co-actor Seasource Holdings Limited (“Seasource”). As of the disclosure date of this announcement, the current holdings reduction plan has passed halfway. Tianjin Sitong and its co-actors Seasource through a major counterparty
Kaisai Biotech (688065.SH): Using centralized bidding to buy back 929,500 company shares
Gelonghui, May 6 | Cathay Biotech (688065.SH) announced that as of April 30, 2024, the company had repurchased 929,464 shares of the company through centralized bidding transactions through the Shanghai Stock Exchange trading system, accounting for 0.1593% of the company's total share capital of 583,378,039 shares. The highest price for the repurchase transaction was RMB 57.37 per share, the lowest price was RMB 38.98 per share, and the total capital paid was RMB 48,418,430.17 (excluding transaction fees such as stamp duty and transaction commissions).
Cathay Biotech Inc.'s (SHSE:688065) Biggest Owners Are Private Companies Who Got Richer After Stock Soared 18% Last Week
Key Insights Cathay Biotech's significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public The top 4 shareholders own 50% of the comp
Cathay Biotech (688065.SH) announced first-quarter results, net profit of 105 million yuan, up 83.25% year-on-year
Cathay Biotech (688065.SH) disclosed its report for the first quarter of 2024. The company achieved operating revenue during the reporting period...
No Data